Clinical Trial

Understanding Acute Dietary Changes After GLP-1 Agonist Treatment: The GLaD Feasibility Study

Study acronym: GLaD
Completed
View on ClinicalTrials.gov →
Summary
An observational study of those who have been prescribed a GLP-1 agonist therapy (yet to commence), for either weight or diabetes management, and are willing to complete dietary records and questionnaires of behaviour and psychosocial health.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-06-01; most recent amendment 2026-02-26.
Status change: Recruiting → Completed 2026-02-26
Status change: Not Yet Recruiting → Recruiting 2025-07-06
Trial Details
NCT Number NCT07001553
Lead Sponsor Australian Catholic University
Collaborators: St Vincent's Hospital Melbourne, The University of Queensland
Conditions Obesity, Type 2 Diabetes Mellitus (T2DM)
Enrollment 37 participants
Start Date 2025-05-28
Primary Completion 2026-01-07 (estimated)
Study Completion 2026-01-07 (estimated)
Updated on ClinicalTrials.gov 2026-03-02